NeuroLucent Inc.
  • Team
  • Our Science
  • IP
  • Patient Resource
  • Contact
Intellectual Property
NeuroLucent's IP & Technology
  • 9 compounds already cleared as effective in AD models, with many more validated core compounds in library
    • ​​Screening in human neurons derived from patients–improves predictive value and chances of success
  • One of the few 2-photon laser imaging systems worldwide that can simultaneously measure both intracellular processes and synaptic function
  • Extensive Patent Protection
Extensive Patent Protection:
  • Patent US20140275112: Compounds for Stabilizing Ryanodine Receptors from Aberrant Levels of Calcium Release: http://www.google.com/patents/US20140275112
  • Published in: USA, Canada, China, European Patent Convention, Pending in Japan
  • A ‘Continuation-in-part’ to protect additional structures, and ‘Composition of matter’ patents under review
  • Exclusive Licensing of all IP from Rosalind Franklin University​
  • Team
  • Our Science
  • IP
  • Patient Resource
  • Contact